Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 346 | 538 | 744 | 939 | 1,326 |
| Marketable Securities | 0 | 1,880 | N/A | N/A | N/A |
| Receivables | 840 | 753 | 663 | 654 | 592 |
| Inventories | N/A | N/A | 0 | 59 | 59 |
| Other current assets | 0 | 411 | 0 | 0 | 0 |
| TOTAL | $1,601 | $3,581 | $1,837 | $2,924 | $3,506 |
| Non-Current Assets | |||||
| PPE Net | 952 | 954 | 942 | 6,930 | 7,039 |
| Investments And Advances | 6,013 | 6,011 | 7,683 | 7,834 | 5,803 |
| Intangibles | 198 | 198 | 198 | 312 | 1,294 |
| Other Non-Current Assets | 672 | 540 | 510 | 861 | 854 |
| TOTAL | $7,835 | $7,703 | $9,333 | $15,936 | $14,990 |
| Total Assets | $9,436 | $11,284 | $11,170 | $18,860 | $18,496 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 0 | 0 | 146 |
| Accounts payable and accrued liabilities | 427 | 417 | 379 | 457 | 259 |
| Accrued Expenses | 143 | N/A | 81 | 90 | 230 |
| Other current liabilities | 407 | 873 | 301 | 517 | 963 |
| TOTAL | $977 | $1,290 | $761 | $2,864 | $3,398 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,365 | 2,644 | 2,869 | 1,020 | 596 |
| Other Non-Current Liabilities | 0 | 42 | -38 | 156 | 887 |
| TOTAL | $2,365 | $2,644 | $2,869 | $1,171 | $1,506 |
| Total Liabilities | $3,342 | $3,934 | $3,630 | $4,035 | $4,904 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,431 | 30,572 | 27,606 | 28,379 | 23,429 |
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -52,442 | -52,010 | -51,252 | -51,111 | -50,527 |
| Other shareholders' equity | -2,055 | -2,057 | -2,150 | -1,887 | -1,826 |
| TOTAL | $6,095 | $7,350 | $7,540 | $14,825 | $13,592 |
| Total Liabilities And Equity | $9,436 | $11,284 | $11,170 | $18,860 | $18,496 |